EC Number | Application | Comment | Organism |
---|---|---|---|
1.13.99.1 | medicine | the enzyme is a possible target for treatment of diabetic kidney disease. MIOX enzyme inhibitor D-glucarate might be a potential therapeutic agent for the amelioration of diabetic kidney disease | Mus musculus |
1.13.99.1 | medicine | the enzyme is a possible target for treatment of diabetic kidney disease. MIOX enzyme inhibitor D-glucarate might be a potential therapeutic agent for the amelioration of diabetic kidney disease | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.13.99.1 | gene MIOX, quantitative enzyme expression analysis | Mus musculus |
1.13.99.1 | gene MIOX, quantitative enzyme expression analysis | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.13.99.1 | D-glucarate | a MIOX inhibitor | Homo sapiens | |
1.13.99.1 | D-glucarate | a MIOX inhibitor, D-glucarate normalizes reduced autophagy and mitophagy in tubules of STZ-induced diabetic mice | Mus musculus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.13.99.1 | mitochondrion | - |
Mus musculus | 5739 | - |
1.13.99.1 | mitochondrion | - |
Homo sapiens | 5739 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.99.1 | myo-inositol + O2 | Mus musculus | - |
D-glucuronate + H2O | - |
? | |
1.13.99.1 | myo-inositol + O2 | Homo sapiens | - |
D-glucuronate + H2O | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.13.99.1 | Homo sapiens | Q9UGB7 | - |
- |
1.13.99.1 | Mus musculus | Q9QXN5 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.13.99.1 | HK-2 cell | - |
Homo sapiens | - |
1.13.99.1 | kidney | - |
Mus musculus | - |
1.13.99.1 | kidney | - |
Homo sapiens | - |
1.13.99.1 | renal tubule | MIOX is a tubular-specific enzyme | Mus musculus | - |
1.13.99.1 | renal tubule | MIOX is a tubular-specific enzyme | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.99.1 | myo-inositol + O2 | - |
Mus musculus | D-glucuronate + H2O | - |
? | |
1.13.99.1 | myo-inositol + O2 | - |
Homo sapiens | D-glucuronate + H2O | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.13.99.1 | MIOX | - |
Mus musculus |
1.13.99.1 | MIOX | - |
Homo sapiens |
1.13.99.1 | Myo-inositol oxygenase | - |
Mus musculus |
1.13.99.1 | Myo-inositol oxygenase | - |
Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
1.13.99.1 | Mus musculus | upregulation of MIOX accompanied by mitochondrial fragmentation and depolarization, inhibition of autophagy/mitophagy, and altered expression of mitochondrial dynamic and mitophagic proteins under high-glucose ambience | up |
1.13.99.1 | Homo sapiens | upregulation of MIOX accompanied by mitochondrial fragmentation and depolarization, inhibition of autophagy/mitophagy, and altered expression of mitochondrial dynamic and mitophagic proteins under high-glucose ambience | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.13.99.1 | malfunction | upregulation of MIOX accompanied by mitochondrial fragmentation and depolarization, inhibition of autophagy/mitophagy, and altered expression of mitochondrial dynamic and mitophagic proteins under high-glucose ambience. Additionally, dysfunctional mitochondria accumulate in the cytoplasm. Decreasing the expression of MIOX under high-glucose ambience increases PTEN-induced putative kinase 1 expression and the dependent mitofusin-2-Parkin interaction. Overexpression of MIOX in the cells enhances the effects of high-glucose, whereas MIOX siRNA or D-glucarate, an inhibitor of MIOX, partially reverse these perturbations | Homo sapiens |
1.13.99.1 | malfunction | upregulation of MIOX accompanied by mitochondrial fragmentation and depolarization, inhibition of autophagy/mitophagy, and altered expression of mitochondrial dynamic and mitophagic proteins under high-glucose ambience. Additionally, dysfunctional mitochondria accumulate in the cytoplasm. Decreasing the expression of MIOX under high-glucose ambience increases PTEN-induced putative kinase 1 expression and the dependent mitofusin-2-Parkin interaction. Overexpression of MIOX in the cells enhances the effects of high-glucose, whereas MIOX siRNA or D-glucarate, an inhibitor of MIOX, partially reverse these perturbations, D-glucarate normalizes reduced autophagy and mitophagy in tubules of STZ-induced diabetic mice | Mus musculus |
1.13.99.1 | metabolism | a mechanism links MIOX to impaired mitochondrial quality control during tubular injury in the pathogenesis of diabetic kidney disease | Mus musculus |
1.13.99.1 | metabolism | a mechanism links MIOX to impaired mitochondrial quality control during tubular injury in the pathogenesis of diabetic kidney disease | Homo sapiens |
1.13.99.1 | physiological function | myo-inositol oxygenase (MIOX) is a tubular-specific enzyme, that modulates redox imbalance and apoptosis in tubular cells in diabetes, role of MIOX in perturbation of mitochondrial quality control, including mitochondrial dynamics and autophagy/mitophagy, under high-glucose ambience or a diabetic state, overview | Mus musculus |
1.13.99.1 | physiological function | myo-inositol oxygenase (MIOX) is a tubular-specific enzyme, that modulates redox imbalance and apoptosis in tubular cells in diabetes, role of MIOX in perturbation of mitochondrial quality control, including mitochondrial dynamics and autophagy/mitophagy, under high-glucose ambience or a diabetic state, overview | Homo sapiens |